Poster: ABCL-366: Mosunetuzumab (Mosun) Monotherapy for Elderly/Unfit Patients with First-Line Diffuse Large B-Cell Lymphoma (DLBCL) Continues to Show Promising Safety and Efficacy with Durable Complete Responses.

Authors :: Olszewski, Adam
Avigdor, Abraham
Babu, Sunil
Levi, Itai
Eradat, Herbert
Abadi, Uri
Holmes, Houston
McKinney, Matthew
Woszczyk, Dariusz
Giannopoulos, Krzysztof
Jurczak, Wojciech
McCord, Ron
Yuying Xie
Mingzhu Zhou
Qayum, Naseer
O'Hear, Carol
Sellam, Gila
Horowitz, Netanel
Source :: Clinical Lymphoma, Myeloma & Leukemia; 2021 Supplement 1, Vol. 21, pS239-S239, 1p
Publication Year :: 2021

Full Text Access

Tools